Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience
Srinivasa, BJ, Lalkota, Bhanu Prakash, Badarke, Girish, Hazarika, Diganta, Mohammad, Nasiruddin, Sapkota, Sulav, Khanderia, Mansi, Tousif, D, Rao, Raghavendra, Ram, Amritanshu, Patil, Shekar, Naik, RaVolume:
12
Language:
english
Journal:
Clinical Medicine Insights: Oncology
DOI:
10.1177/1179554918782475
Date:
January, 2018
File:
PDF, 114 KB
english, 2018